Obtained pre-A round of investment from 'National Venture Capital', 'Xiangshang Investment', 'Jiangmen Taikang' and other institutions
May 10, 2021
QuaCell Biotechnology completed the pre-A round of financing and obtained tens of millions of investment from Guangdong National Innovation Investment Management Co., Ltd. ("National Venture Capital"), Zhongshan Xiangshang Investment Management Co., Ltd. ("Xiangshang Investment")and Jiangmen Taikang Investment Partnership Co., Ltd. ("Jiangmen Taikang").
QuaCell Biotechnology's Notice on Strengthening the Disinfection of Product Packaging before Shipment
February 8, 2021
QuaCell Biotechnology implements temporary outer packaging disinfection measures to deliver the full line of cell culture media, culture supplement products, and technical service deliveries.